Keyphrases
Head-and-neck Cancer
100%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
95%
Molecular Mechanism
79%
Preventive Medicine
70%
Cancer Stem Cells
70%
Predictive Medicine
70%
Cancer Stem Cell Therapy
70%
Oral Cancer Stem Cells
70%
Virulence Factors
70%
HPV-related Cancers
70%
Oncogenic Function
70%
Host Immune Response
70%
Epidermal Growth Factor Receptor
70%
Therapeutic Implications
70%
Periodontal Pathogens
70%
Personalized Medicine
70%
Oncogenesis
70%
Phosphorylation
70%
Evade
70%
Therapeutic Challenges
70%
Targeted Therapy
70%
Epidermal Growth Factor Receptor Pathway Substrate 8 (EPS8)
70%
Angiogenesis
70%
Zoledronate
70%
C-X-C Chemokine Receptor Type 4 (CXCR4)
70%
Preosteoblast
70%
Stromal Cell-derived factor-1 (SDF-1)
70%
Disease Progression
55%
Clinical Outcomes
44%
Therapeutic Intervention
44%
Aurora Kinase A (AURKA)
44%
Alveolar Bone
38%
Molecular Targets
35%
Monoclonal Antibody
35%
Alisertib
35%
Tyrosine Kinase Inhibitor
35%
Erlotinib
35%
TP53 mutation
35%
Kinase Activity
35%
Overexpression
35%
Small Molecule Tyrosine Kinase Inhibitors
35%
Clinical Response
35%
Multimodal Approach
35%
Salivary Diagnostics
35%
Disease Prevention
35%
Cyclin-dependent Kinase Inhibitor
35%
Liquid Biopsy
35%
Disease Behavior
35%
Palbociclib
35%
Upper Aerodigestive Tract
35%
Pharmacology, Toxicology and Pharmaceutical Science
Head and Neck Cancer
93%
Head and Neck Squamous Cell Carcinoma
85%
Disease
85%
Epidermal Growth Factor Receptor
70%
Protein P53
70%
Malignant Neoplasm
70%
Protein Tyrosine Kinase Inhibitor
70%
Mouth Cancer
70%
Stromal Cell Derived Factor 1
70%
Zoledronic Acid
70%
Disease Exacerbation
42%
Neoplasm
38%
Metastasis
35%
Monoclonal Antibody
35%
Tumor Recurrence
35%
Erlotinib
35%
Cyclin Dependent Kinase Inhibitor
35%
Cetuximab
35%
Papillomaviridae
35%
Gefitinib
35%
Cycline
35%
Disease Course
35%
Carcinogen
35%
Aurora Kinase
35%
Ethanol
35%
Alisertib
35%
Cyclin Dependent Kinase
35%
Palbociclib
35%
Tamsulosin
35%
Tumor Growth
15%
Messenger RNA
15%
Prevalence
7%
Preclinical Study
7%
Clinical Trial
7%
Clinical Research
7%
Carcinogenicity
7%
Melanoma
7%
Biological Marker
7%
Salivary Gland Tumor
7%
Squamous Cell Carcinoma
7%
Tooth Injury
7%
Jaw Osteonecrosis
7%
Flow Cytometry
7%
Bone Necrosis
7%
Disease Predisposition
7%
Medicine and Dentistry
Cancer Stem Cell
70%
Oral Cancer
70%
Dasatinib
70%
Osteoclast
70%
Zoledronic Acid
70%
Stromal Cell Derived Factor 1
70%
Angiogenesis
70%
Mitogenesis
46%
Alveolar Bone
38%
Malignant Neoplasm
38%
Neoplasm
31%
Carcinogenicity
31%
Actin
23%
Receptor
23%
Immunofluorescence
23%
Protein Phosphorylation
23%
Carcinogenesis
23%
Tyrosine
23%
Cell Cycle
23%
Biological Functions
23%
Western Blot
23%
Phenylalanine
23%
Scaffold Protein
23%
Plasmid
23%
Wound Closure
23%
Head and Neck Cancer
23%
Metastatic Carcinoma
23%
Cancer
15%
Tumor Progression
15%
Targeted Therapy
15%
Head and Neck Squamous Cell Carcinoma
15%
Disease
15%
In Vitro
15%
Messenger RNA
15%
Squamous Cell Carcinoma
7%
Clinical Trial
7%
Drive
7%
Molecular Mechanism of Cancer
7%
Nodular Melanoma
7%
Disease Exacerbation
7%
Prevalence
7%
Clinical Study
7%
Biological Marker
7%
Tumor Cell
7%
Salivary Gland Neoplasm
7%
Clinical Research
7%
Bone Necrosis
7%
Dental Trauma
7%
Downregulation
7%
Tooth Extraction
7%